Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01795638 · ClinicalTrials.gov registry record · Phase 4
Sodium Supplementation and Growth in Very Low Birth Weight Infants
A Phase 4 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Terminated
- Registry status
- Phase 4
- Development phase
- 53
- Enrollment target
NCT01795638 is a Phase 4 study that was terminated before completion, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 53 participants.
The verdict
NCT01795638, a Phase 4 study, was terminated before completion, sponsored by Children's Hospital Medical Center, Cincinnati.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 53 participants
- Enrollment target
Study Summary
Adequate growth during the neonatal period is critical for optimal long term outcomes. Despite maximal calorie intake, sixty percent of very low birth weight infants still fail to thrive suggesting that factors other than total calorie intake are important in ensuring consistent weight gain. Several reports have indicated a positive sodium balance is critical in ensuring good weight gain in very low birth weight infants, however these infants are susceptible to low serum sodium concentrations. Urine sodium values are sometimes used to diagnosis of hyponatremia or negative sodium balance after the first two weeks of life, but there is no evidence for this practice in preterm neonates. Our central hypothesis is that early supplementation with sodium will ensure positive sodium balance in very low birth weight infants and will result in optimal weight gain and enhanced long term outcomes. Secondarily we hypothesize that low sodium concentrations in the urine will not correlate with low serum sodium values.
Interventions
- DRUG Placebo
- DRUG Sodium chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01795638
The ClinicalTrials.gov registry entry for NCT01795638 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01795638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01795638 about?
NCT01795638 is a clinical study titled "Sodium Supplementation and Growth in Very Low Birth Weight Infants". Adequate growth during the neonatal period is critical for optimal long term outcomes. Despite maximal calorie intake, sixty percent of very low birth weight infants still fail to thrive suggesting that factors other than total calorie intake are important in ensuring consistent weight gain. Several...
What is the current status of trial NCT01795638?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 53 participants. The study started on 2009-10. Estimated completion is 2011-01.
What interventions are being tested in trial NCT01795638?
The interventions under investigation include: Placebo (DRUG), Sodium chloride (DRUG).
Who is sponsoring clinical trial NCT01795638?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.